Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor

Open access
Klegeris, Andis, Bissonnette, Christopher J, McGeer, Patrick L·2003·British Journal of Pharmacology

Abstract

Two cannabinoid receptors, CB1 and CB2, have been identified. The CB1 receptor is preferentially expressed in brain, and the CB2 receptor in cells of leukocyte lineage. We identified the mRNA for the CB1 receptor in human neuroblastoma SH‐SY5Y cells, and the mRNA and protein for the CB2 receptor in human microglia and THP‐1 cells. Δ 9‐and Δ 8‐tetrahydrocannabinol (THC) were toxic when added directly to SH‐SY5Y neuroblastoma cells. The toxicity of Δ 9‐ THC was inhibited by the CB1 receptor antagonist SR141716A but not by the CB2 receptor antagonist SR144528. The endogenous ligand anandamide was also toxic, and this toxicity was enhanced by inhibitors of its enzymatic hydrolysis. The selective CB2 receptor ligands JWH‐015 and indomethacin morpholinylamide (BML‐190), when added to THP‐1 cells before stimulation with lipopolysaccharide (LPS) and IFN‐γ, reduced the toxicity of their culture supernatants to SH‐SY5Y cells. JWH‐015 was more effective against neurotoxicity of human microglia than THP‐1 cells. The antineurotoxic activity of JWH‐015 was blocked by the selective CB2 receptor antagonist SR144528, but not by the CB1 receptor antagonist SR141716A. This activity of JWH‐015 was synergistic with that of the 5‐lipoxygenase (5‐LOX) inhibitor REV 5901. Cannabinoids inhibited secretion of IL‐1 β and tumor necrosis factor‐α (TNF‐α) by stimulated THP‐1 cells, but these effects could not be directly correlated with their antineurotoxic activity. Specific CB2 receptor ligands could be useful anti‐inflammatory agents, while avoiding the neurotoxic and psychoactive effects of CB1 receptor ligands such as Δ 9‐THC. British Journal of Pharmacology (2003) 139, 775–786. doi:10.1038/sj.bjp.0705304

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705304

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 246

Metadata

Authors
Klegeris, A., Bissonnette, C. J., & McGeer, P. L.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2003-06
Volume
139
Issue
4
Pages
775-786
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2017876495
Cited by
246
References
7
FWCI
7.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor. https://app.cochat.ai/papers/10.1038/sj.bjp.0705304
The paper
Klegeris, A., Bissonnette, C. J., & McGeer, P. L. (2003). Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid‐type CB2 receptor. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705304

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.